2017 Switzerland Automated Microbiology Market: Molecular Diagnostics, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics-- Specimen, Test, and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com examines current and emerging assays; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay and application; profiles leading players and potential market entrants; and suggests alternative market penetration strategies for suppliers.
Rationale
The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.
The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems.The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans.Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.
The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.
This report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.
Market Segmentation Analysis
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Technology Review
Rationale
The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.
The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems.The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans.Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.
The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.
This report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.
Market Segmentation Analysis
- Volume and sales forecasts for over 100 infectious disease assays by individual test.
- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
- Urine
- Sterile Fluids: Blood, Serum, CSF
- Throat Swabs, Respiratory Secretions
- Genital Secretions
- Stool
- Abscess/Wound
- Sputum
- Saliva
- Microbial Identification
- Antibiotic Susceptibility
- Urine Screening
- Blood Cultures
- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Technology Review
- Assessment of molecular diagnostic, monoclonal antibody, immunoassay,and other technologies and their potential applications for the microbiology market.
- Global listings of companies developing or marketing microbiology products by individual test.
- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
1. INTRODUCTION
2. MARKET OVERVIEW
3. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
4. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
5. ALTERNATIVE MARKET PENETRATION STRATEGIES
6. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
7. MAJOR CURRENT AND EMERGING CANCER DIAGNOSTIC TESTS
1. INTRODUCTION
2. CANCER DIAGNOSTIC CLASSIFICATION
3. ACTH
4. ALPHA FETOPROTEIN (AFP)
5. BETA 2 MICROGLOBULIN
6. CA 15 3/27.29
7. CA 199
8. CA 125
9. CALCITONIN
10. CARCINOEMBRIONIC ANTIGEN (CEA)
11. ESTROGEN AND PROGESTERONE RECEPTORS
12. FERRITIN
13. GASTRIN
14. HUMAN CHORIONIC GONADOTROPIN (HCG)
15. INSULIN
16. NSE
17. OCCULT BLOOD
18. PAP SMEAR/HPV
19. PROSTATIC ACID PHOSPHATASE (PAP)
20. PROSTATE SPECIFIC ANTIGEN (PSA)
21. SQUAMOUS CELL CARCINOMA ANTIGEN (SCC)
22. T AND B LYMPHOCYTES
23. TDT
24. THYROGLOBULIN
25. TISSUE POLYPEPTIDE ANTIGEN (TPA)
26. BIOCHEMICAL CANCER DIAGNOSTICS
27. ONCOGENES
Abl/abl bcr
AIB1
BCL2
BRCA1
CD44
C-fos
C-myb
C-myc
CYP 17
ErbB
HPC1
Nmyc
P40
P51
P53
PIK3CA
PTI1
Ras
Reg
Sis
Src
28. POLYPEPTIDE GROWTH FACTORS
Basic Fibroblast Growth Factor
Beta TGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth Factor Alpha
29. ECTOPIC HORMONES
30. COLONY STIMULATING FACTORS
31. LYMPHOKINES
Alpha Interferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
Gamma Interferon
Interleukin 1 (IL1)
Macrophage Activating Factor
32. IMMUNOHISTOCHEMICAL STAINS
33. EMERGING CANCER DIAGNOSTICS
NAcetylglucosamine
Actin
Alpha Actin
Antineuronal Antibodies
7B2
B72.3
Bax
BCD F9
BLCA 4
Blood Group Antigens A, B, H
CA
CA 72 4/TAG 72
CA
CA 242
CA 549
CAM
CAR 3
Cathepsin D
Chromogranin A and B
Cluster 1 Antigen
Cluster 5/5A Antigen
CTA
CU18
DR 70
DU AN2
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
Feulgen Hydrolysis
Fibronectin
FSH
(1 >3) Lfucosyltransferase
Gastrin Releasing Peptide (GRP)
GDCFP 15
Glucagon
Glycoamines
H23
Her 2
Human Carcinoma Antigen
HPA
HSP27
Intermediate Filaments
Cytokeratins/CK18/Cyfra 21 1
Desmin
Gliofibrillary Acid Protein
Neurofilaments
Vimentin
KA
Kinases
KP16D3
LAI
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma
MABDF3
MAG
ME1
Minactivin
MN/CA9
MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor
Myosin
NEA 130
NMP22
OA 519
Opiod Peptides
P glycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92
Proliferative Index, Ki 67
Px
RB Inactivation/Deletion
Ret
SCCL
Selectin
Sialic Acid
Sialyl SSEA 1/SLX
SN10
Somatostatin
TA 90
TABA
Tachykinin
TAG
TPS
Troponin
Tubulin
VCAM
VEGF
Villen
8. INSTRUMENTATION REVIEW AND MARKET NEEDS
9. CURRENT AND EMERGING TECHNOLOGIES
1. MONOCLONAL AND POLYCLONAL ANTIBODIES
2. IMMUNOASSAYS
3. MOLECULAR DIAGNOSTICS
4. CHROMOSOME ANALYSIS
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. ARTIFICIAL INTELLIGENCE
6. FLOW CYTOMETRY
7. TW DIMENSIONAL GEL ELECTROPHORESIS (2 DGE)
8. BIOSENSORS
9. COMPETING/COMPLEMENTING TECHNOLOGIES
10. MARKET SIZE, TEST VOLUME AND SALES FORECASTS
11. COMPETITIVE PROFILES
Abbott
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Genrobe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Thermo Fisher/Affimetrix
Veridex
Wako Pure Chemicals
Wallac/PE
Zila
12. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS
2. MARKET OVERVIEW
3. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
4. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
5. ALTERNATIVE MARKET PENETRATION STRATEGIES
6. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
7. MAJOR CURRENT AND EMERGING CANCER DIAGNOSTIC TESTS
1. INTRODUCTION
2. CANCER DIAGNOSTIC CLASSIFICATION
3. ACTH
4. ALPHA FETOPROTEIN (AFP)
5. BETA 2 MICROGLOBULIN
6. CA 15 3/27.29
7. CA 199
8. CA 125
9. CALCITONIN
10. CARCINOEMBRIONIC ANTIGEN (CEA)
11. ESTROGEN AND PROGESTERONE RECEPTORS
12. FERRITIN
13. GASTRIN
14. HUMAN CHORIONIC GONADOTROPIN (HCG)
15. INSULIN
16. NSE
17. OCCULT BLOOD
18. PAP SMEAR/HPV
19. PROSTATIC ACID PHOSPHATASE (PAP)
20. PROSTATE SPECIFIC ANTIGEN (PSA)
21. SQUAMOUS CELL CARCINOMA ANTIGEN (SCC)
22. T AND B LYMPHOCYTES
23. TDT
24. THYROGLOBULIN
25. TISSUE POLYPEPTIDE ANTIGEN (TPA)
26. BIOCHEMICAL CANCER DIAGNOSTICS
27. ONCOGENES
Abl/abl bcr
AIB1
BCL2
BRCA1
CD44
C-fos
C-myb
C-myc
CYP 17
ErbB
HPC1
Nmyc
P40
P51
P53
PIK3CA
PTI1
Ras
Reg
Sis
Src
28. POLYPEPTIDE GROWTH FACTORS
Basic Fibroblast Growth Factor
Beta TGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth Factor Alpha
29. ECTOPIC HORMONES
30. COLONY STIMULATING FACTORS
31. LYMPHOKINES
Alpha Interferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
Gamma Interferon
Interleukin 1 (IL1)
Macrophage Activating Factor
32. IMMUNOHISTOCHEMICAL STAINS
33. EMERGING CANCER DIAGNOSTICS
NAcetylglucosamine
Actin
Alpha Actin
Antineuronal Antibodies
7B2
B72.3
Bax
BCD F9
BLCA 4
Blood Group Antigens A, B, H
CA
CA 72 4/TAG 72
CA
CA 242
CA 549
CAM
CAR 3
Cathepsin D
Chromogranin A and B
Cluster 1 Antigen
Cluster 5/5A Antigen
CTA
CU18
DR 70
DU AN2
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
Feulgen Hydrolysis
Fibronectin
FSH
(1 >3) Lfucosyltransferase
Gastrin Releasing Peptide (GRP)
GDCFP 15
Glucagon
Glycoamines
H23
Her 2
Human Carcinoma Antigen
HPA
HSP27
Intermediate Filaments
Cytokeratins/CK18/Cyfra 21 1
Desmin
Gliofibrillary Acid Protein
Neurofilaments
Vimentin
KA
Kinases
KP16D3
LAI
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma
MABDF3
MAG
ME1
Minactivin
MN/CA9
MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor
Myosin
NEA 130
NMP22
OA 519
Opiod Peptides
P glycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92
Proliferative Index, Ki 67
Px
RB Inactivation/Deletion
Ret
SCCL
Selectin
Sialic Acid
Sialyl SSEA 1/SLX
SN10
Somatostatin
TA 90
TABA
Tachykinin
TAG
TPS
Troponin
Tubulin
VCAM
VEGF
Villen
8. INSTRUMENTATION REVIEW AND MARKET NEEDS
9. CURRENT AND EMERGING TECHNOLOGIES
1. MONOCLONAL AND POLYCLONAL ANTIBODIES
2. IMMUNOASSAYS
3. MOLECULAR DIAGNOSTICS
4. CHROMOSOME ANALYSIS
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. ARTIFICIAL INTELLIGENCE
6. FLOW CYTOMETRY
7. TW DIMENSIONAL GEL ELECTROPHORESIS (2 DGE)
8. BIOSENSORS
9. COMPETING/COMPLEMENTING TECHNOLOGIES
10. MARKET SIZE, TEST VOLUME AND SALES FORECASTS
11. COMPETITIVE PROFILES
Abbott
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/Genrobe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Thermo Fisher/Affimetrix
Veridex
Wako Pure Chemicals
Wallac/PE
Zila
12. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS
LIST OF TABLES
Cancer Diagnostic Test Volume and Sales Forecasts
Cancer Diagnostic Volume Forecast by Test
Cancer Diagnostics Sales Forecast by Test
ACTH Test Volume and Diagnostics Sales Forecast
AFP Test Volume and Diagnostics Sales Forecast
Beta 2 Microglobulin Test Volume and Diagnostics Sales Forecast
CA 15 3/27.29 Test Volume and Diagnostics Sales Forecast
CA 199 Test Volume and Diagnostics Sales Forecast
CA 125 Test Volume and Diagnostics Sales Forecast
Calcitonin Test Volume and Diagnostics Sales Forecast
Cathepsin Test Volume and Diagnostics Sales Forecast
CEA Test Volume and Diagnostics Sales Forecast
Chromogranin Test Volume and Diagnostics Sales Forecast
Colon specific Antigen Test Volume and Diagnostics Sales Forecast
Cytokeratins Test Volume and Diagnostics Sales Forecast
Estrogen Receptor Test Volume and Diagnostics Sales Forecast
Ferritin Test Volume and Diagnostics Sales Forecast
Gastrin Test Volume and Diagnostics Sales Forecast
HCG Test Volume and Diagnostics Sales Forecast
Insulin Test Volume and Diagnostics Sales Forecast
Interferons Test Volume and Diagnostics Sales
Interleukins Test Volume and Diagnostics Sales Forecast
Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast
NSE Test Volume and Diagnostics Sales Forecast
Nucleolar Test Volume and Diagnostics Sales Forecast
Occult Blood Test Volume and Diagnostics Sales Forecast
Oncogenes Test Volume and Diagnostics Sales Forecast
Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast
PAP Smear Test Volume and Diagnostics Sales Forecast
Parathyroid Hormone Test Volume and Diagnostics Sales Forecast
Progesterone Receptor Test Volume and Diagnostics Sales Forecast
PAP Test Volume and Diagnostics Sales Forecast
PSA Test Volume and Diagnostics Sales Forecast
S 100 Protein Test Volume and Diagnostics Sales Forecast
Serotonin Test Volume and Diagnostics Sales Forecast
Sialic Acid Test Volume and Diagnostics Sales Forecast
Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast
TDT Test Volume and Diagnostics Sales Forecast
Thymidine Kinase Test Volume and Diagnostics Sales Forecast
Thyroglobulin Test Volume and Diagnostics Sales Forecast
TPA Test Volume and Diagnostics Sales Forecast
Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta 2 Microglobulin Tests
Major Companies Developing or Marketing CA 15 3/27.29 Tests
Major Companies Developing or Marketing CA 199 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications in Cancer Diagnosis
Oncogenes Potential Applications in Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications in Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications in Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Cancer Diagnostic Test Volume and Sales Forecasts
Cancer Diagnostic Volume Forecast by Test
Cancer Diagnostics Sales Forecast by Test
ACTH Test Volume and Diagnostics Sales Forecast
AFP Test Volume and Diagnostics Sales Forecast
Beta 2 Microglobulin Test Volume and Diagnostics Sales Forecast
CA 15 3/27.29 Test Volume and Diagnostics Sales Forecast
CA 199 Test Volume and Diagnostics Sales Forecast
CA 125 Test Volume and Diagnostics Sales Forecast
Calcitonin Test Volume and Diagnostics Sales Forecast
Cathepsin Test Volume and Diagnostics Sales Forecast
CEA Test Volume and Diagnostics Sales Forecast
Chromogranin Test Volume and Diagnostics Sales Forecast
Colon specific Antigen Test Volume and Diagnostics Sales Forecast
Cytokeratins Test Volume and Diagnostics Sales Forecast
Estrogen Receptor Test Volume and Diagnostics Sales Forecast
Ferritin Test Volume and Diagnostics Sales Forecast
Gastrin Test Volume and Diagnostics Sales Forecast
HCG Test Volume and Diagnostics Sales Forecast
Insulin Test Volume and Diagnostics Sales Forecast
Interferons Test Volume and Diagnostics Sales
Interleukins Test Volume and Diagnostics Sales Forecast
Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast
NSE Test Volume and Diagnostics Sales Forecast
Nucleolar Test Volume and Diagnostics Sales Forecast
Occult Blood Test Volume and Diagnostics Sales Forecast
Oncogenes Test Volume and Diagnostics Sales Forecast
Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast
PAP Smear Test Volume and Diagnostics Sales Forecast
Parathyroid Hormone Test Volume and Diagnostics Sales Forecast
Progesterone Receptor Test Volume and Diagnostics Sales Forecast
PAP Test Volume and Diagnostics Sales Forecast
PSA Test Volume and Diagnostics Sales Forecast
S 100 Protein Test Volume and Diagnostics Sales Forecast
Serotonin Test Volume and Diagnostics Sales Forecast
Sialic Acid Test Volume and Diagnostics Sales Forecast
Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast
TDT Test Volume and Diagnostics Sales Forecast
Thymidine Kinase Test Volume and Diagnostics Sales Forecast
Thyroglobulin Test Volume and Diagnostics Sales Forecast
TPA Test Volume and Diagnostics Sales Forecast
Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta 2 Microglobulin Tests
Major Companies Developing or Marketing CA 15 3/27.29 Tests
Major Companies Developing or Marketing CA 199 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications in Cancer Diagnosis
Oncogenes Potential Applications in Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications in Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications in Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis